<--- Back to Details
First PageDocument Content
Health / HIV/AIDS / Hepatitis / Cytokines / Hepatitis C and HIV co-infection / Hepatitis C virus / Hepatitis C / Peginterferon alfa-2a / Needlestick injury / Medicine / Antivirals / Biology
Date: 2014-05-20 21:56:19
Health
HIV/AIDS
Hepatitis
Cytokines
Hepatitis C and HIV co-infection
Hepatitis C virus
Hepatitis C
Peginterferon alfa-2a
Needlestick injury
Medicine
Antivirals
Biology

AASLD PRACTICE GUIDELINES Diagnosis, Management, and Treatment of Hepatitis C: An Update Marc G. Ghany,1 Doris B. Strader,2 David L. Thomas,3 and Leonard B. Seeff4 This document has been approved by the AASLD, the Infect

Add to Reading List

Source URL: www.som.uq.edu.au

Download Document from Source Website

File Size: 564,67 KB

Share Document on Facebook

Similar Documents

Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study

Acute Hepatitis C in the PROUD pilot study Juan Tiraboschi, Liz Brodnicki, Brady Michael, John Saunders, Schembri Gabriel, Mark Roche, Julie Fox on behalf of the PROUD study

DocID: 1vngt - View Document

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C   New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

PRESS RELEASE AbbVie Receives Health Canada Approval of HOLKIRATM PAK for the Treatment of Chronic Genotype 1 Hepatitis C  New all-oral, short-course (12 weeks), interferon-free treatment available in Canada for geno

DocID: 1vlwz - View Document

PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

PRESS RELEASE AbbVie’s MAVIRET™ Approved by Health Canada for the Treatment of Chronic Hepatitis C in All Major Genotypes   

DocID: 1vjI2 - View Document

APASL and CEVHAP Partnership: a Hepatitis-Free World November

APASL and CEVHAP Partnership: a Hepatitis-Free World November

DocID: 1vgwC - View Document

California Institute of Technology Hepatitis B Vaccination Offer Form Occupational Exposure to Bloodborne Pathogens Please complete this form if you may come in contact with human blood or other potentially infectious hu

California Institute of Technology Hepatitis B Vaccination Offer Form Occupational Exposure to Bloodborne Pathogens Please complete this form if you may come in contact with human blood or other potentially infectious hu

DocID: 1vf93 - View Document